|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.300 SEK | +0.39% |
|
-3.35% | -37.20% |
| 06-17 | Axichem AB Elects Michael Engstrom As Chairman Of The Board | RE |
| 06-12 | Calendar Monday June 15 - Friday June 19 | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -16.45 | -15.15 | -17.64 | -14.57 | -16.15 | |||||
Return on Total Capital | -17.13 | -15.76 | -18.36 | -15.34 | -17.11 | |||||
Return On Equity % | -27.45 | -35.73 | -46.85 | -30.02 | -28.67 | |||||
Return on Common Equity | -27.45 | -35.73 | -46.87 | -30.03 | -28.67 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 20.84 | 76.25 | 77.89 | 82.63 | 49.23 | |||||
SG&A Margin | 297.36 | 294.81 | 858.76 | 211.74 | 114.47 | |||||
EBITDA Margin % | -309.63 | -248.39 | -834.88 | -157.29 | -81.4 | |||||
EBITA Margin % | -310.52 | -249.21 | -836.26 | -157.48 | -81.44 | |||||
EBIT Margin % | -345.48 | -290.49 | -957.32 | -184.68 | -94.82 | |||||
Income From Continuing Operations Margin % | -346.01 | -344.72 | -1.15K | -207.88 | -95.61 | |||||
Net Income Margin % | -346.01 | -344.66 | -1.15K | -207.85 | -95.59 | |||||
Net Avail. For Common Margin % | -346.01 | -344.66 | -1.15K | -207.85 | -95.59 | |||||
Normalized Net Income Margin | -215.76 | -215.08 | -718.08 | -129.67 | -59.65 | |||||
Levered Free Cash Flow Margin | -337.46 | -328.8 | -826.04 | -145.02 | -52.74 | |||||
Unlevered Free Cash Flow Margin | -337.43 | -295.22 | -706.12 | -130.76 | -52.34 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.08 | 0.08 | 0.03 | 0.13 | 0.27 | |||||
Fixed Assets Turnover | 41.74 | 69.06 | 45.8 | 451.05 | 2.64K | |||||
Receivables Turnover (Average Receivables) | 3.45 | 1.33 | 0.42 | 1.96 | 4.21 | |||||
Inventory Turnover (Average Inventory) | 1.74 | 0.27 | 0.05 | 0.18 | 1.19 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 7.27 | 0.89 | 1.35 | 6.8 | 1.84 | |||||
Quick Ratio | 5.85 | 0.57 | 0.62 | 4.82 | 0.83 | |||||
Operating Cash Flow to Current Liabilities | -7.48 | -0.91 | -1.21 | -2.79 | -1.38 | |||||
Days Sales Outstanding (Average Receivables) | 105.89 | 275.3 | 872.75 | 187.08 | 86.74 | |||||
Days Outstanding Inventory (Average Inventory) | 209.35 | 1.33K | 6.8K | 2.04K | 305.93 | |||||
Average Days Payable Outstanding | 90.78 | 79.97 | 111.97 | 1.5K | 69.84 | |||||
Cash Conversion Cycle (Average Days) | 224.46 | 1.53K | 7.56K | 729.69 | 322.83 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | - | 46.51 | 21.16 | - | 8.94 | |||||
Total Debt / Total Capital | - | 31.75 | 17.46 | - | 8.21 | |||||
LT Debt/Equity | - | - | - | - | - | |||||
Long-Term Debt / Total Capital | - | - | - | - | - | |||||
Total Liabilities / Total Assets | 4.21 | 34.16 | 21.08 | 5.55 | 13.45 | |||||
EBIT / Interest Expense | -7.54K | -5.41 | -4.99 | -8.09 | -148.23 | |||||
EBITDA / Interest Expense | -6.75K | -4.62 | -4.35 | -6.89 | -127.25 | |||||
(EBITDA - Capex) / Interest Expense | -6.76K | -4.62 | -4.35 | -6.89 | -127.25 | |||||
Total Debt / EBITDA | - | -1.51 | -0.68 | - | -0.31 | |||||
Net Debt / EBITDA | 0.7 | -0.98 | -0.39 | 1.07 | -0.11 | |||||
Total Debt / (EBITDA - Capex) | - | -1.51 | -0.68 | - | -0.31 | |||||
Net Debt / (EBITDA - Capex) | 0.7 | -0.98 | -0.39 | 1.07 | -0.11 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 255.5 | 14.79 | -63.87 | 373.74 | 115.24 | |||||
Gross Profit, 1 Yr. Growth % | 52.52 | 320.02 | -63.1 | 402.56 | 28.24 | |||||
EBITDA, 1 Yr. Growth % | 12.44 | -7.92 | 21.44 | -10.75 | 11.39 | |||||
EBITA, 1 Yr. Growth % | 12.45 | -7.88 | 21.24 | -10.79 | 11.31 | |||||
EBIT, 1 Yr. Growth % | 11.52 | -3.48 | 19.06 | -8.61 | 10.51 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 11.68 | 14.36 | 20.59 | -14.41 | -1 | |||||
Net Income, 1 Yr. Growth % | 11.68 | 14.34 | 20.59 | -14.41 | -1.01 | |||||
Normalized Net Income, 1 Yr. Growth % | 11.43 | 14.43 | 20.63 | -14.46 | -0.99 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 8.92 | 12.95 | -1.31 | -55.12 | -35.1 | |||||
Accounts Receivable, 1 Yr. Growth % | 2.81K | 108.66 | -30.57 | 47.14 | -31.92 | |||||
Inventory, 1 Yr. Growth % | 88.28 | 135.06 | 45.12 | -12.08 | 2.33 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -19.83 | -44.09 | -48.08 | -59.26 | -72.73 | |||||
Total Assets, 1 Yr. Growth % | 5.43 | 4.22 | 0.39 | 20.8 | -17.75 | |||||
Tangible Book Value, 1 Yr. Growth % | 10.81 | -55.28 | 67.43 | 105.54 | -38.29 | |||||
Common Equity, 1 Yr. Growth % | 4.94 | -28.41 | 20.34 | 44.59 | -24.64 | |||||
Cash From Operations, 1 Yr. Growth % | 33.36 | 22.46 | -17.91 | -26.62 | -1.36 | |||||
Capital Expenditures, 1 Yr. Growth % | -52.94 | - | - | - | - | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 3.73 | 14.88 | -9.23 | -16.83 | -21.73 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 3.73 | 3.16 | -13.58 | -12.27 | -13.85 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 256.61 | 102.01 | -35.6 | 30.83 | 219.32 | |||||
Gross Profit, 2 Yr. CAGR % | 389.09 | 153.1 | 24.5 | 36.18 | 153.87 | |||||
EBITDA, 2 Yr. CAGR % | 10.45 | 1.75 | 5.75 | 4.11 | -0.29 | |||||
EBITA, 2 Yr. CAGR % | 10.49 | 1.78 | 5.68 | 4 | -0.35 | |||||
EBIT, 2 Yr. CAGR % | 10.12 | 3.75 | 7.2 | 4.31 | 0.5 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 9.68 | 13.01 | 17.43 | 1.6 | -7.95 | |||||
Net Income, 2 Yr. CAGR % | 9.68 | 13 | 17.42 | 1.6 | -7.95 | |||||
Normalized Net Income, 2 Yr. CAGR % | 9.56 | 12.92 | 17.49 | 1.58 | -7.97 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 8.02 | 10.92 | 5.58 | -33.45 | -46.03 | |||||
Accounts Receivable, 2 Yr. CAGR % | 165.17 | 679.65 | 20.36 | 1.07 | 0.08 | |||||
Inventory, 2 Yr. CAGR % | 60.36 | 110.38 | 84.7 | 12.96 | -5.15 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -10.07 | -33.05 | -46.12 | -54.01 | -66.67 | |||||
Total Assets, 2 Yr. CAGR % | -7.74 | 4.82 | 2.29 | 10.13 | -0.32 | |||||
Tangible Book Value, 2 Yr. CAGR % | -14.45 | -29.6 | -13.47 | 85.51 | 12.62 | |||||
Common Equity, 2 Yr. CAGR % | -8.45 | -13.32 | -7.18 | 31.91 | 4.39 | |||||
Cash From Operations, 2 Yr. CAGR % | 13.27 | 27.79 | 0.26 | -22.39 | -14.93 | |||||
Capital Expenditures, 2 Yr. CAGR % | -49.6 | - | - | - | - | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 14.29 | 7.71 | 2.12 | -13.11 | -19.32 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 14.66 | 2.06 | -5.58 | -12.93 | -13.07 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 133.19 | 144.4 | 13.81 | 25.25 | 54.45 | |||||
Gross Profit, 3 Yr. CAGR % | 91.22 | 364.89 | 33.22 | 98.23 | 33.48 | |||||
EBITDA, 3 Yr. CAGR % | 15.79 | 3.95 | 7.93 | -0.06 | 6.48 | |||||
EBITA, 3 Yr. CAGR % | 15.83 | 3.99 | 7.89 | -0.12 | 6.38 | |||||
EBIT, 3 Yr. CAGR % | 15.95 | 5.39 | 8.62 | 1.65 | 6.34 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 14.99 | 11.22 | 15.48 | 5.68 | 0.72 | |||||
Net Income, 3 Yr. CAGR % | 14.99 | 11.21 | 15.48 | 5.68 | 0.72 | |||||
Normalized Net Income, 3 Yr. CAGR % | 14.9 | 11.16 | 15.43 | 5.69 | 0.72 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 11.54 | 9.64 | 6.68 | -20.61 | -34 | |||||
Accounts Receivable, 3 Yr. CAGR % | - | 144.81 | 248.16 | 28.7 | -11.4 | |||||
Inventory, 3 Yr. CAGR % | 236.33 | 82.16 | 85.88 | 44.21 | 9.3 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 6.96 | -23.25 | -38.49 | -50.91 | -61.36 | |||||
Total Assets, 3 Yr. CAGR % | 15.2 | -3.91 | 3.32 | 8.12 | -0.08 | |||||
Tangible Book Value, 3 Yr. CAGR % | 170.55 | -31.08 | -6.03 | 15.46 | 28.54 | |||||
Common Equity, 3 Yr. CAGR % | 24.61 | -15.65 | -3.3 | 7.6 | 9.46 | |||||
Cash From Operations, 3 Yr. CAGR % | 27.86 | 16.25 | 10.26 | -9.65 | -15.93 | |||||
Capital Expenditures, 3 Yr. CAGR % | -44.18 | - | - | - | - | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 27.36 | 13.47 | 1.74 | -4.63 | -16.09 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 28.23 | 9.7 | -3.44 | -7.87 | -13.24 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | - | - | 39.37 | 90.34 | 71.95 | |||||
Gross Profit, 5 Yr. CAGR % | - | - | 61.06 | 184.49 | 72.42 | |||||
EBITDA, 5 Yr. CAGR % | - | - | 11.66 | 4.01 | 4.56 | |||||
EBITA, 5 Yr. CAGR % | 17.98 | 11.69 | 11.66 | 3.99 | 4.52 | |||||
EBIT, 5 Yr. CAGR % | 20.52 | 15.16 | 12.37 | 4.96 | 5.3 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 19.97 | 18.54 | 15.96 | 7.26 | 5.47 | |||||
Net Income, 5 Yr. CAGR % | 19.97 | 18.53 | 15.96 | 7.26 | 5.46 | |||||
Normalized Net Income, 5 Yr. CAGR % | 19.92 | 18.5 | 15.93 | 7.23 | 5.43 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 7.45 | 15.94 | 9.12 | -10.2 | -18.77 | |||||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | 71.85 | 111.45 | |||||
Inventory, 5 Yr. CAGR % | 79.71 | 132.25 | 164.63 | 50.47 | 42.03 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | -18.7 | -37.46 | -51.86 | |||||
Total Assets, 5 Yr. CAGR % | 4.57 | 9.7 | 9.85 | 1.47 | 1.85 | |||||
Tangible Book Value, 5 Yr. CAGR % | 10.98 | 10.75 | 71.48 | 2.41 | 1.03 | |||||
Common Equity, 5 Yr. CAGR % | 6.38 | 3.55 | 10.76 | 0.87 | -0.3 | |||||
Cash From Operations, 5 Yr. CAGR % | 23.06 | 19.96 | 16.01 | -1.1 | -0.6 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -9.95 | 15.27 | 15.97 | 1.98 | -7.27 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -9.88 | 12.48 | 12.84 | 0.02 | -7.41 |
- Stock Market
- Stocks
- AXIC A Stock
- Financials aXichem AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















